Epigen Biosciences, Inc. SBIR Phase II Award, September 2023
A SBIR Phase II contract was awarded to Epigen Biosciences, Inc. in September, 2023 for $971,732.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
Currently, there are no issues on this topic.
Find more entities like Epigen Biosciences, Inc. SBIR Phase II Award, September 2023
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.